World GI Congress | Conferences

Pooled Data Suggest Obese Patients With CRC May Benefit From Weight-Based Chemotherapy Doses

July 02, 2021

Findings from the OCTOPUS Consortium of trial data have indicated that obese patients with colorectal cancer have a poorer survival from adjuvant chemotherapy treatment due to reduced treatment dose and average cumulative relative dose.